KKNMS criticizes abuses in ASV multiple sclerosis
In a statement, the Multiple Sclerosis Competence Network has denounced administrative and content-related deficits in outpatient specialist care for MS patients. The ASV-MS, introduced in 2024, does not meet its goals of better coordination and quality improvement, as bureaucratic hurdles and regional inequalities make access difficult. With the expiry of the transitional periods in 2026, there is a risk of deterioration.
The ASV combines outpatient and inpatient resources to efficiently treat complex conditions such as MS, without budget constraints. But the application process is overloaded, admission criteria too complex, especially for doctors in private practice. State practice varies greatly: Extended state committees examine inconsistently, which leads to inequalities – in some federal states, clinics dominate, in others approvals are disproportionately high.
In terms of content, relevant services such as cognitive tests, fatigue questionnaires, serum neurofilament measurements and optical coherence tomography are missing, while superfluous such as cardiological expertise is planned. Team leaders need specific qualifications beyond case numbers; the KKNMS proposes certification.
Demands include monitoring of the ELA procedures for standardization, liberalization of specialties, introduction of a quality system with comparison to standard care, ASV-specific criteria for services, addition to the service catalog, opening of the catalog of therapeutic products and abolition of the referral obligation for long-term care.
The KKNMS calls for discussions with stakeholders and G-BA in order to remedy grievances and strengthen the ASV as an instrument for evidence-based, equitable care.
Original Paper:
Statement on grievances in current ASV multiple sclerosis – Competence Network Multiple Sclerosis
Editor: X-Press Journalistenbüro GbR
Gender Notice. The personal designations used in this text always refer equally to female, male and diverse persons. Double/triple naming and gendered designations are used for better readability. ected.
Most read
Laboratory medicine: Chrysanthi Skevaki becomes new director in Mainz As of January 1, 2026, Chrysanthi Skevaki will take over as head of the Institute of Clinical Chemis...- Groundbreaking urine test could revolutionize bladder cancer diagnosis Researchers have found that analyzing specific patterns of cell-free DNA (cfDNA) fragmentation in a...
- Important changes for privately insured persons in 2026 From 2026, significant changes will come into force for privately insured persons, including higher...
